Dear All,
I am happy to let you know that few of my advice and strategic proposal to develop the Bangladesh Pharmaceuticals sectors is working. I have been pushing various pharmaceuticals companies including Bangladesh Drug Administration to encourage manufacturing quality medicines since 2006.
I believe that few them took my advice with great respect and is working to improve manufacturing capabilities with new technologies available in the world. I still believe that Middle East countries is the Goldmine for getting Pharmaceuticals investment in Bangladesh and asking CTG to formulate a program to attract investment from their excess wealth of US$2 Trillion.
I am still asking CTG to implement my comprehensive proposal to develop Bangladesh Pharmaceutical sector. This proposal will create 10 Lac jobs in Bangladesh in the next 5 years and export can be reached to US$5 Billion in 5 years.
Regards,
M. M. Chowdhury (Mithu)
--------------------------------------------------------------------------------------------------------------------
Pharmaceutical Exports
F.M. Masum back from Tongi
Gulf Cooperation Council (GCC) countries are considering to import pharmaceutical products worth Tk 3000 crore every year from Bangladesh. A high-power business delegation of the GCC countries Tuesday expressed satisfaction over the quality and price of medicines manufactured in the Beximco plants. "We are very much satisfied about the quality of Bangladeshi medicine. We just came here to judge the quality of the pharmaceutical products. The quality of products is amazing it is beyond our expectation," said Dr Alaa Rady, a member of the visiting delegation.
"We are pleased seeing the quality and price of the medicine manufactured here. Personally I can say that the infrastructures and facilities here are amazing and equivalent to European and other developed countries' standards," Dr Bader Alanzi, another member of the delegation told reporters. He said, "This is start of the exporting process and we are keenly interested to import pharmaceutical products from Bangladesh but for that we have to work together and it is not that we are going to start importing drugs from tomorrow. But we are hopeful that, after completing the necessary processes, BPL will start exporting to the GCC countries very soon."
The Chief Executive Officer of Beximco Pharmaceuticals Ltd , Nazmul Hassan said, "Middle East is considered as a high potential market and with the establishment of a common market of GCC countries; this region has become one of the most lucrative pharmaceutical markets of the world." He said, "Pharmaceutical products of Bangladesh have enormous exporting opportunities in the various countries in the world and it is one of the most potentials sector after Ready Made Garments (RMG), After successfully qualifying through this audit the company will be able export its medicine to the GCC countries and this will create an enormous opportunity for Bangladesh as a whole."
He said," the Government gives all out supports to the industry, Bangladesh can export a total of Tk10000 crore by the year 2009. The Government should pull out the barriers of registration to promote the export to the various countries and if Bangladesh can avail only in its one percent market." Nazmul Hassan said, "If we can export such big amount of pharmaceutical products, the other countries of the world will be encouraged and that can play a vital role in the economic sector like RMG sector. This is a great opportunity to export to the Gulf region and this will also act as a gateway for Bangladeshi pharmaceutical industry for exporting medicines to this huge market. "
It may be mentioned that the combined pharmaceutical market of the GCC countries is currently valued at over $ 4 billion. Beximco Pharmaceuticals is one of the world's 15 companies and the first in the country, which is producing CFC (Chroroflurocarbon) free and HFA-enriched MDIs, used in asthma and COPD. It may also be mentioned here that under the Quota protocol, the signatory countries are prescribed to stop producing CFC-enriched asthma products by 2008.
F.M. Masum back from Tongi
Gulf Cooperation Council (GCC) countries are considering to import pharmaceutical products worth Tk 3000 crore every year from Bangladesh. A high-power business delegation of the GCC countries Tuesday expressed satisfaction over the quality and price of medicines manufactured in the Beximco plants. "We are very much satisfied about the quality of Bangladeshi medicine. We just came here to judge the quality of the pharmaceutical products. The quality of products is amazing it is beyond our expectation," said Dr Alaa Rady, a member of the visiting delegation.
"We are pleased seeing the quality and price of the medicine manufactured here. Personally I can say that the infrastructures and facilities here are amazing and equivalent to European and other developed countries' standards," Dr Bader Alanzi, another member of the delegation told reporters. He said, "This is start of the exporting process and we are keenly interested to import pharmaceutical products from Bangladesh but for that we have to work together and it is not that we are going to start importing drugs from tomorrow. But we are hopeful that, after completing the necessary processes, BPL will start exporting to the GCC countries very soon."
The Chief Executive Officer of Beximco Pharmaceuticals Ltd , Nazmul Hassan said, "Middle East is considered as a high potential market and with the establishment of a common market of GCC countries; this region has become one of the most lucrative pharmaceutical markets of the world." He said, "Pharmaceutical products of Bangladesh have enormous exporting opportunities in the various countries in the world and it is one of the most potentials sector after Ready Made Garments (RMG), After successfully qualifying through this audit the company will be able export its medicine to the GCC countries and this will create an enormous opportunity for Bangladesh as a whole."
He said," the Government gives all out supports to the industry, Bangladesh can export a total of Tk10000 crore by the year 2009. The Government should pull out the barriers of registration to promote the export to the various countries and if Bangladesh can avail only in its one percent market." Nazmul Hassan said, "If we can export such big amount of pharmaceutical products, the other countries of the world will be encouraged and that can play a vital role in the economic sector like RMG sector. This is a great opportunity to export to the Gulf region and this will also act as a gateway for Bangladeshi pharmaceutical industry for exporting medicines to this huge market. "
It may be mentioned that the combined pharmaceutical market of the GCC countries is currently valued at over $ 4 billion. Beximco Pharmaceuticals is one of the world's 15 companies and the first in the country, which is producing CFC (Chroroflurocarbon) free and HFA-enriched MDIs, used in asthma and COPD. It may also be mentioned here that under the Quota protocol, the signatory countries are prescribed to stop producing CFC-enriched asthma products by 2008.
[Disclaimer: ALOCHONA Management is not liable for information contained in this message. The author takes full responsibility.]
To unsubscribe/subscribe, send request to alochona-owner@egroups.com
Your email settings: Individual Email|Traditional
Change settings via the Web (Yahoo! ID required)
Change settings via email: Switch delivery to Daily Digest | Switch to Fully Featured
Visit Your Group | Yahoo! Groups Terms of Use | Unsubscribe
Change settings via the Web (Yahoo! ID required)
Change settings via email: Switch delivery to Daily Digest | Switch to Fully Featured
Visit Your Group | Yahoo! Groups Terms of Use | Unsubscribe
__,_._,___